These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 19438539

  • 21. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
    O'Brien ME, Saini A, Smith IE, Webb A, Gregory K, Mendes R, Ryan C, Priest K, Bromelow KV, Palmer RD, Tuckwell N, Kennard DA, Souberbielle BE.
    Br J Cancer; 2000 Oct; 83(7):853-7. PubMed ID: 10970684
    [Abstract] [Full Text] [Related]

  • 22. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation.
    Kopp MV, Hennemuth I, Heinzmann A, Urbanek R.
    Pediatrics; 2008 Apr; 121(4):e850-6. PubMed ID: 18332075
    [Abstract] [Full Text] [Related]

  • 23. Risk factors for atopic dermatitis in New Zealand children at 3.5 years of age.
    Purvis DJ, Thompson JM, Clark PM, Robinson E, Black PN, Wild CJ, Mitchell EA.
    Br J Dermatol; 2005 Apr; 152(4):742-9. PubMed ID: 15840107
    [Abstract] [Full Text] [Related]

  • 24. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH, Lee KH, Jautova J, Wohlrab J, Guettner A, Mizutani G, Hultsch T.
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [Abstract] [Full Text] [Related]

  • 25. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL, Kamya RM, Okwera A, Loughlin AM, Nyole S, Hom DL, Wallis RS, Hirsch CS, Wolski K, Foulds J, Mugerwa RD, Ellner JJ.
    J Infect Dis; 2000 Apr; 181(4):1304-12. PubMed ID: 10753731
    [Abstract] [Full Text] [Related]

  • 26. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
    Friedmann PS, Palmer R, Tan E, Ogboli M, Barclay G, Hotchkiss K, Berth-Jones J.
    Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
    [Abstract] [Full Text] [Related]

  • 27. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
    Heshmat NM, El-Hadidi ES.
    Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
    [Abstract] [Full Text] [Related]

  • 28. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
    Hon KL, Lam MC, Leung TF, Wong KY, Chow CM, Fok TF, Ng PC.
    Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
    [Abstract] [Full Text] [Related]

  • 29. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S.
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [Abstract] [Full Text] [Related]

  • 30. Long-term follow-up of atopic dermatitis: retrospective analysis of related risk factors and association with concomitant allergic diseases.
    Ricci G, Patrizi A, Baldi E, Menna G, Tabanelli M, Masi M.
    J Am Acad Dermatol; 2006 Nov; 55(5):765-71. PubMed ID: 17052480
    [Abstract] [Full Text] [Related]

  • 31. [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis].
    Luo Y, National Cooperation Group On Clinical Study Of Mycobacterium Vaccae Vaccine.
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):43-7. PubMed ID: 11802939
    [Abstract] [Full Text] [Related]

  • 32. Lactobacillus salivarius plus fructo-oligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a double-blind, randomized, clinical trial of efficacy and safety.
    Wu KG, Li TH, Peng HJ.
    Br J Dermatol; 2012 Jan; 166(1):129-36. PubMed ID: 21895621
    [Abstract] [Full Text] [Related]

  • 33. Montelukast treatment in children with moderately severe atopic dermatitis.
    Ehlayel MS, Bener A, Sabbah A.
    Eur Ann Allergy Clin Immunol; 2007 Sep; 39(7):232-6. PubMed ID: 18236999
    [Abstract] [Full Text] [Related]

  • 34. Early atopic disease and early childhood immunization--is there a link?
    Grüber C, Warner J, Hill D, Bauchau V, EPAAC Study Group.
    Allergy; 2008 Nov; 63(11):1464-72. PubMed ID: 18925883
    [Abstract] [Full Text] [Related]

  • 35. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP, Whalley D, de Prost Y, Staab D, Huels J, Paul CF, van Assche D.
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
    [Abstract] [Full Text] [Related]

  • 36. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA, Lamerson C, Sheehan MP, Boguniewicz M, Mosser J, Raimer S, Shull T, Jaracz E, US Tacrolimus Ointment Study Group.
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [Abstract] [Full Text] [Related]

  • 37. Atopic dermatitis in young children is associated with impaired interleukin-10 and interferon-gamma responses to allergens, vaccines and colonizing skin and gut bacteria.
    Dunstan JA, Hale J, Breckler L, Lehmann H, Weston S, Richmond P, Prescott SL.
    Clin Exp Allergy; 2005 Oct; 35(10):1309-17. PubMed ID: 16238790
    [Abstract] [Full Text] [Related]

  • 38. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure.
    Wang IJ, Wang JY.
    Clin Exp Allergy; 2015 Apr; 45(4):779-87. PubMed ID: 25600169
    [Abstract] [Full Text] [Related]

  • 39. Is topical antimycotic treatment useful as adjuvant therapy for flexural atopic dermatitis: randomized, double-blind, controlled trial using one side of the elbow or knee as a control.
    Wong AW, Hon EK, Zee B.
    Int J Dermatol; 2008 Feb; 47(2):187-91. PubMed ID: 18211496
    [Abstract] [Full Text] [Related]

  • 40. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C, Maintz L, Hart J, Allam JP, Vrtala S, Chen KW, Bieber T, Thomas WR, Valenta R, Zuberbier T, Sager A, Novak N.
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.